AJR ARRS Membership
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, K. H. Y.
Right arrow Articles by Hanbidge, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, K. H. Y.
Right arrow Articles by Hanbidge, A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
AJR 2004; 182:643-649
© American Roentgen Ray Society


Triple-Phase MDCT of Hepatocellular Carcinoma

K. H. Y. Lee1, M. E. O'Malley1,2, M. A. Haider1 and A. Hanbidge1

1 Department of Medical Imaging, University Health Network and Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada.
2 Department of Medical Imaging, NCSB, 1C558, Toronto General Hospital, 585 University Ave., Toronto M5G 2N2, ON, Canada.

OBJECTIVE. The purpose of this study was to describe the appearances of hepatocellular carcinoma including intralesional contrast washout using a triple-phase liver protocol on an MDCT scanner.

MATERIALS AND METHODS. Fifty-one patients with newly diagnosed hepatocellular carcinoma underwent standardized triple-phase CT using a multidetector scanner. Pathologic proof was obtained in 35 patients (69%); in 16 patients (31%), hepatocellular carcinoma was diagnosed on clinical and laboratory findings. Two radiologists independently reviewed the CT studies for the appearance and attenuation of the lesions. Intralesional washout of contrast material was evaluated subjectively and objectively. Statistical analysis was performed using Fisher's exact test to analyze the relationships between tumor appearance and {alpha}-fetoprotein level, tumor grade, and risk factor. Correlation between tumor size and appearance was analyzed using the Student's t test and Wilcoxon's rank sum test.

RESULTS. The most common enhancement pattern for hepatocellular carcinoma was hypervascularity on hepatic arterial phase images with a mosaic pattern on both arterial and portal venous images; this finding was seen in 86% and 78% of lesions by the two observers, respectively. A hypervascular component was seen in 96% of lesions by both observers, and the observers recorded 86% and 63% of lesions as showing washout, respectively. Objective washout was present in 76% of lesions. Both subjective and objective washout correlated with an elevated {alpha}-fetoprotein level (p = 0.01).

CONCLUSION. The appearances of hepatocellular carcinoma on images obtained using MDCT scanners are similar to those described for images obtained using single-detector helical scanners. However, the prevalence of hypervascular hepatocellular carcinoma on MDCT images is higher than previously described on single-detector helical images and most lesions showed washout on portal venous MDCT images.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Roentgenol.Home page
F. Hughes-Cassidy, J. Wong, D. Aguirre, A. D. Chavez, T. Wolfson, A. Gamst, and C. Sirlin
Transient Homogeneously Enhancing Hepatic Masses: Can Size Predict Benignity?
Am. J. Roentgenol., February 1, 2008; 190(2): 300 - 307.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
H.-J. Jang, T. K. Kim, P. N. Burns, and S. R. Wilson
Enhancement Patterns of Hepatocellular Carcinoma at Contrast-enhanced US: Comparison with Histologic Differentiation
Radiology, September 1, 2007; 244(3): 898 - 906.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Radiol.Home page
C-S Li, R-C Chen, H-Y Tu, L-S Shih, T-A Zhang, J-M Lii, W-T Chen, S-J Duh, and L-C Chiang
Imaging well-differentiated hepatocellular carcinoma with dynamic triple-phase helical computed tomography
Br. J. Radiol., August 1, 2006; 79(944): 659 - 665.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
M. M. Bittle and F. S. Chew
Imaging of Hepatocellular Carcinoma: Self-Assessment Module
Am. J. Roentgenol., June 1, 2006; 186(6_Supplement_1): S431 - S433.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
M. M. Bittle and F. S. Chew
Radiological Reasoning: Incidentally Discovered Liver Mass
Am. J. Roentgenol., June 1, 2006; 186(6_Supplement_1): S434 - S441.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
E. P. Tamm and P. M. Silverman
"Computed Tomography of the Liver"--A Commentary.
Am. J. Roentgenol., May 1, 2006; 186(5): 1217 - 1219.
[Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
P. T. Johnson and E. K. Fishman
IV Contrast Selection for MDCT: Current Thoughts and Practice
Am. J. Roentgenol., February 1, 2006; 186(2): 406 - 415.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American Roentgen Ray Society.